Synthetic Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Synthetic Genomics's estimated annual revenue is currently $17.2M per year.
- Synthetic Genomics's estimated revenue per employee is $155,000
- Synthetic Genomics's total funding is $175M.
Employee Data
- Synthetic Genomics has 111 Employees.
- Synthetic Genomics grew their employee count by 7% last year.
Synthetic Genomics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP DNA Technology | Reveal Email/Phone |
3 | VP Development and Deployment | Reveal Email/Phone |
4 | VP HR | Reveal Email/Phone |
5 | VP, Business Development | Reveal Email/Phone |
6 | VP, Research | Reveal Email/Phone |
7 | Head Business Development | Reveal Email/Phone |
8 | Director Phototrophic Production | Reveal Email/Phone |
9 | Director Human Resources | Reveal Email/Phone |
10 | Director Facilities and Environmental Health & Safety | Reveal Email/Phone |
Synthetic Genomics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.9M | 233 | 56% | $4.5M | $221M |
#2 | $14.4M | 103 | -65% | $74M | N/A |
What Is Synthetic Genomics?
Synthetic Genomics, Inc. was founded in 2005 to develop and commercialize recently discovered and potentially world-changing genomic synthesis technologies. We are applying new scientific advances, including newly discovered genetic sequences of novel photosynthetic and metabolic pathways, to execute various life functions within a synthetically devised organism. These breakthroughs present unprecedented opportunities that could restructure and revolutionize the manufacture of chemicals, pharmaceuticals and energy, as well as present unique ways to enable carbon sequestration and environmental remediation. At Synthetic Genomics, Inc. we are focusing our work first in the area of ethanol and hydrogen production.
keywords:N/A
$175M
Total Funding
111
Number of Employees
$17.2M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Synthetic Genomics News
Mr. Zhang pioneered the development of genome editing tools, and studies the genetics and epigenetics of human diseases and disorders. With...
... Inc. (U.S.), New England Biolabs (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Synthetic Genomics, Inc. (U.S.).
Genscript Biotech, Integrated DNA, Ginkgo Bioworks, Agilent, Thermo Fisher, BBI, Eurofins Genomics, Genewiz, Synthetic Genomics,...
Emily Leproust Contributor Emily Leproust is CEO of Twist Bioscience. More posts by this contributor Beyond The $1K Genome: DNA ‘Writing’ Comes Next Synthetic biology (synbio for short) is a term that circulates freely through the tech world, but what exactly does it mean? It inspires both ex ...
Share Share on Facebook Share on Twitter LinkedIn Email Reprints San Diego’s Synthetic Genomics and Texas-based ExxonMobil celebrated the first anniversary of their strategic alliance today with the official opening of a greenhouse for growing and testing algae that could someday replace crude ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.3M | 111 | -10% | N/A |
#2 | $39.2M | 111 | -1% | N/A |
#3 | $22.8M | 111 | -6% | N/A |
#4 | $27.9M | 111 | 18% | N/A |
#5 | $35M | 111 | 4% | N/A |